[PMU17] Additional benefit scoring during health technology assessment in Germany its drivers and impact on pricing and discount for orphan drugs
HomePublications[PMU17] Additional benefit scoring during health technology assessment in Germany its drivers and impact on pricing and discount for orphan drugs